Committee for Medicinal Products for Veterinary Use
E24385
The Committee for Medicinal Products for Veterinary Use is the European Medicines Agency’s scientific committee responsible for evaluating and providing opinions on veterinary medicines in the European Union.
All labels observed (4)
How this entity was disambiguated
This entity first appeared as the object of triple T184501 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
Target entity: Committee for Medicinal Products for Veterinary Use Context triple: [European Medicines Agency, hasCommittee, Committee for Medicinal Products for Veterinary Use]
-
A.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
B.
European Medicines Agency
The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
-
C.
European Directorate for the Quality of Medicines & HealthCare
The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
-
D.
UK Medicines and Healthcare products Regulatory Agency
The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
-
E.
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Target entity: Committee for Medicinal Products for Veterinary Use Target entity description: The Committee for Medicinal Products for Veterinary Use is the European Medicines Agency’s scientific committee responsible for evaluating and providing opinions on veterinary medicines in the European Union.
-
A.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
B.
European Medicines Agency
The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
-
C.
European Directorate for the Quality of Medicines & HealthCare
The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
-
D.
UK Medicines and Healthcare products Regulatory Agency
The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
-
E.
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
- F. None of above. chosen
Statements (49)
| Predicate | Object |
|---|---|
| instanceOf |
European Union body
ⓘ
regulatory committee ⓘ scientific committee ⓘ |
| abbreviation |
Committee for Medicinal Products for Veterinary Use
self-linksurface differs
ⓘ
surface form:
CVMP
|
| appliesTo |
antimicrobial veterinary medicines
ⓘ
antiparasitic veterinary medicines ⓘ immunological veterinary medicinal products ⓘ medicated feed ⓘ pharmacological veterinary medicinal products ⓘ veterinary biologicals ⓘ veterinary medicinal products ⓘ veterinary vaccines ⓘ |
| country | Belgium ⓘ |
| field |
animal health
ⓘ
pharmacology ⓘ public health ⓘ regulatory science ⓘ veterinary medicine ⓘ |
| hasCommitteeType |
Committee for Medicinal Products for Veterinary Use
self-linksurface differs
ⓘ
surface form:
scientific committee of EMA
|
| jurisdiction | European Union ⓘ |
| language | English ⓘ |
| location |
Amsterdam
ⓘ
European Medicines Agency ⓘ
surface form:
European Medicines Agency headquarters
Netherlands ⓘ |
| operatedBy | European Medicines Agency ⓘ |
| parentOrganization | European Medicines Agency ⓘ |
| partOf | European Medicines Agency ⓘ |
| responsibleFor |
centralised procedure for veterinary medicinal products
ⓘ
scientific evaluation of extensions to veterinary marketing authorisations ⓘ scientific evaluation of referrals for veterinary medicinal products ⓘ scientific evaluation of variations to veterinary marketing authorisations ⓘ scientific evaluation of veterinary marketing authorisation applications ⓘ |
| role |
advise on maximum residue limits for veterinary medicinal products
ⓘ
assess efficacy of veterinary medicines ⓘ assess quality of veterinary medicines ⓘ assess safety of veterinary medicines ⓘ contribute to development of guidelines for veterinary medicinal products ⓘ contribute to risk management of veterinary medicinal products ⓘ cooperate with national competent authorities for veterinary medicines ⓘ evaluate veterinary medicinal products ⓘ prepare opinions on marketing authorisation applications for veterinary medicines ⓘ prepare opinions on pharmacovigilance issues for veterinary medicines ⓘ prepare opinions on post-authorisation changes for veterinary medicines ⓘ provide scientific advice to applicants for veterinary medicines ⓘ provide scientific opinions on veterinary medicines ⓘ support harmonisation of veterinary medicine regulation in the EU ⓘ |
| sector |
animal health products
ⓘ
veterinary pharmaceuticals ⓘ |
| website | https://www.ema.europa.eu/en/committees/committee-medicinal-products-veterinary-use-cvmp ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Subject: Committee for Medicinal Products for Veterinary Use Description of subject: The Committee for Medicinal Products for Veterinary Use is the European Medicines Agency’s scientific committee responsible for evaluating and providing opinions on veterinary medicines in the European Union.
Referenced by (5)
Full triples — surface form annotated when it differs from this entity's canonical label.